Continuous versus pulsatile administration of erythropoietin (EPO) via the uterus in anemic rats
- 20 October 1994
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 111 (2) , 197-202
- https://doi.org/10.1016/0378-5173(94)00144-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- What we have learned from recent IUD studies: A researcher's perspectiveContraception, 1993
- The TCu-380a (Ag), MLCu375, and Nova-T LUDs and the IUD daily releasing 20 μg levonorgestrel-four pillars of IUD contraception for the nineties and beyond?Contraception, 1993
- A New Route of Drug Administration: Intrauterine Delivery of Insulin and CalcitoninPharmaceutical Research, 1993
- Effects of Salicylate and Other Enhancers on Rectal Absorption of Erythropoietin in RatsJournal of Pharmacy and Pharmacology, 1992
- Effect of Recombinant Human Erythropoietin on New Anaemic Model Rats Induced by GentamicinJournal of Pharmacy and Pharmacology, 1990
- The delivery of peptidesJournal of Pharmaceutical Sciences, 1989
- PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSISThe Lancet, 1989
- Systemic delivery of therapeutic peptides and proteinsInternational Journal of Pharmaceutics, 1988
- RECOMBINANT HUMAN ERYTHROPOIETIN IN ANAEMIC PATIENTS ON HAEMODIALYSISThe Lancet, 1987
- Chronic intravenous cannulas for ratsJournal of Applied Physiology, 1964